Pennsylvania HB111 prohibits insurers from discriminating against applicants or enrollees based on opioid overdose reversal agent prescriptions.
Pennsylvania HB111, also known as Lloyd's Law, prohibits insurers from taking adverse actions against applicants or enrollees based solely on prior or current claims or prescriptions for opioid overdose reversal agents. Adverse actions include denying, canceling, or refusing to renew insurance coverage, limiting the amount or kind of coverage, or charging different rates. The law defines adverse action and specifies that it applies to individual applicants, enrollees, or groups.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.